Handbook of Pharmaceutical Manufacturing Formulations, Second Edition

Handbook of pharmaceutical manufacturing formulations , Handbook of pharmaceutical manufacturing formulations , کتابخانه دیجیتال جندی شاپور اهواز

[1]  I. Mcmillan,et al.  Comparative bioavailabilities from truncated blood level curves. , 1975, Journal of pharmaceutical sciences.

[2]  S. Yoshioka,et al.  Assessment of Shelf-Life Equivalence of Pharmaceutical Products , 1997 .

[3]  J. Moan,et al.  Epidemiological Support for an Hypothesis for Melanoma Induction Indicating a Role for UVA Radiation , 1999, Photochemistry and photobiology.

[4]  S. Navaratnam,et al.  Primary Photophysical Properties of Ofloxacin¶ , 2000, Photochemistry and photobiology.

[5]  H. Mukhtar,et al.  Kinetics of UV Light–induced Cyclobutane Pyrimidine Dimers in Human Skin In Vivo: An Immunohistochemical Analysis of both Epidermis and Dermis , 2000, Photochemistry and photobiology.

[6]  M. Holdiness.  A review of contact dermatitis associated with transdermal therapeutic systems , 1989, Contact dermatitis.

[7]  J. Heylings,et al.  Influence of dibutyl phthalate on dermal sensitization to fluorescein isothiocyanate. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[8]  Michael Levin,et al.  Supac-Mr: Modified Release Solid Oral Dosage Forms‚ÄîScale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation , 2001 .

[9]  李幼升,et al.  Ph , 1989 .

[10]  Hongshik Ahn,et al.  Shelf-Life Estimation for Multifactor Stability Studies , 1997 .

[11]  G. Sher,et al.  Out of Control* , 2006, Ethics.

[12]  M. S. Islam,et al.  Photoprotection of daunorubicin hydrochloride with sodium sulfite. , 1995, PDA journal of pharmaceutical science and technology.

[13]  J. Carstensen,et al.  Pharmaceutics of solids and solid dosage forms , 1977 .

[14]  Dennis J. Cada,et al.  Sodium Ferric Gluconate Complex in Sucrose Injection , 1999 .

[15]  William R. Fairweather,et al.  Regulatory, design, and analysis aspects of complex stability studies. US Food & Drug Administration. , 1995, Journal of pharmaceutical sciences.

[16]  B.K. Yi,et al.  Digital signatures , 2006, IEEE Potentials.

[17]  D. Mitchell,et al.  Xeroderma pigmentosum variant with multisystem involvement. , 1992, Archives of dermatology.

[18]  H. Maibach,et al.  Animal, Human and In Vitro Test Methods for Predicting Skin Irritation , 2004 .

[19]  Stephen J. Ruberg,et al.  Multiple comparison procedures for pooling batches in stability studies , 1992 .

[20]  C. Brownie,et al.  In vitro percutaneous absorption of benzidine in complex mechanistically defined chemical mixtures. , 1996, Toxicology and applied pharmacology.

[21]  Index , 1999, Neuroscience.

[22]  H. Hönigsmann,et al.  Photopatch testing: the 5-year experience of the German, Austrian, and Swiss Photopatch Test Group. , 1991, Journal of the American Academy of Dermatology.

[23]  N. Gibbs,et al.  FAILURE OF UVR DOSE RECIPROCITY FOR SKIN TUMORIGENESIS IN HAIRLESS MICE TREATED WITH 8‐METHOXYPSORALEN , 1985, Photochemistry and photobiology.

[24]  R. Lavker,et al.  The spectral dependence for UVA-induced cumulative damage in human skin. , 1997, The Journal of investigative dermatology.

[25]  David N. Weil,et al.  Full Disclosure , 1996 .

[26]  A. Kligman,et al.  Topical photosensitizers. Influence of vehicles on penetration. , 1974, Archives of dermatology.

[27]  M Liebsch,et al.  The International EU/COLIPA In Vitro Phototoxicity Validation Study: Results of Phase II (Blind Trial). Part 1: The 3T3 NRU Phototoxicity Test. , 1998, Toxicology in vitro : an international journal published in association with BIBRA.

[28]  L. Joshi,et al.  Bioprospecting in plants for engineered proteins. , 2005, Current opinion in plant biology.

[29]  S. Richard,et al.  A Reappraisal of the 21-Day Cumulative Irritation Test in Man , 1982 .

[30]  N. Gibbs,et al.  Quinolone antibiotic with potential to photosensitize skin tumorigenesis. , 1997, Journal of photochemistry and photobiology. B, Biology.

[31]  B. Eberlein-König,et al.  Phototoxicity of non-steroidal anti-inflammatory drugs: in vitro studies with visible light. , 1996, Acta dermato-venereologica.

[32]  K. Midha,et al.  The bioequivalence of highly variable drugs and drug products. , 2005, International journal of clinical pharmacology and therapeutics.

[33]  C. Blichmann,et al.  A simple method for the study of scale pattern and effects of a moisturizer–qualitative and quantitative evaluation by D‐Squame® tape compared with parameters of epidermal hydration , 1989, Clinical and experimental dermatology.

[34]  H. Schaefer,et al.  Follicles play an important role in percutaneous absorption. , 1991, Journal of pharmaceutical sciences.

[35]  L. Benet,et al.  Interpretation of plasma concentration-time curves after oral dosing. , 1977, Journal of pharmaceutical sciences.

[36]  F. Nielloud,et al.  Stability of UV Filters in Different Vehicles: Solvents and Emulsions , 1997 .

[37]  A. Kornhauser,et al.  Animal Models for Phototoxicity Testing , 1996 .

[38]  D. Hoppensteadt,et al.  Development of generic low molecular weight heparins: a perspective. , 2005, Hematology/oncology clinics of North America.

[39]  D. H. Besterfield.  Quality control , 1979 .

[40]  D. V. van Thiel,et al.  Non-lymphoid cancer after liver transplantation. , 1997, Hepato-gastroenterology.

[41]  David Z. D'Argenio,et al.  Optimal sampling times for pharmacokinetic experiments , 1981, Journal of Pharmacokinetics and Biopharmaceutics.

[42]  V. Shah,et al.  Acyclovir bioavailability in human skin. , 1992, The Journal of investigative dermatology.

[43]  Robert G. Easterling,et al.  Discrimination Intervals for Percentiles in Regression , 1969 .

[44]  H. Maibach,et al.  Photoirritation (Phototoxicity, Phototoxic Dermatitis) , 2004 .

[45]  A. Jacobs,et al.  Does Photosensitivity Predict Photococarcinogenicity? , 1999 .

[46]  Lawrence X. Yu,et al.  Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs). , 2004, Advanced drug delivery reviews.

[47]  R. Stern,et al.  Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis. , 1998, Archives of dermatology.

[48]  Robert L. Grossman,et al.  Timed Automata , 1999, CAV.

[49]  C. Lathers.  Challenges and opportunities in animal drug development: a regulatory perspective , 2003, Nature Reviews Drug Discovery.

[50]  S. Seité,et al.  All-trans-retinoic acid enhances collagen gene expression in irradiated and non-irradiated hairless mouse skin. , 1997, Journal of photochemistry and photobiology. B, Biology.

[51]  A. Asker,et al.  Influence of Certain Additives on the Photostability of Physosticmine Sulfate Solutions , 1988 .

[52]  S. Ruberg,et al.  Pooling data for stability studies: testing the equality of batch degradation slopes. , 1991, Biometrics.

[53]  Sue-Jane Wang,et al.  A Regulatory Perspective on Choice of Margin and Statistical Inference Issue in Non‐inferiority Trials , 2005, Biometrical journal. Biometrische Zeitschrift.

[54]  H. Schaefer,et al.  Role of transepidermal and transfollicular routes in percutaneous absorption of steroids: in vitro studies on human skin. , 1994, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[55]  J. Haynes,et al.  Worldwide virtual temperatures for product stability testing. , 1971, Journal of pharmaceutical sciences.

[56]  Donald J. Schuirmann.  A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability , 1987, Journal of Pharmacokinetics and Biopharmaceutics.

[57]  Eduardo Kac,et al.  Time capsule , 2000, AI & SOCIETY.

[58]  C. Scaletta,et al.  Sunlight and carcinogenesis: Expression of p53 and pyrimidine dimers in human skin following UVA I, UVA I + II and solar simulating radiations , 1998, International journal of cancer.

[59]  H. Maibach,et al.  Regional variation in percutaneous absorption in man: measurement by the stripping method , 2004, Archives of Dermatological Research.

[60]  Harald Schumny,et al.  Next generation , 2005, Comput. Stand. Interfaces.

[61]  E. Abel.  Cutaneous manifestations of immunosuppression in organ transplant recipients. , 1989, Journal of the American Academy of Dermatology.

[62]  R. Weale.  Photobiology of the Skin and Eye , 1987 .

[63]  H. Maibach.  Dermatologic research techniques , 1996 .

[64]  W. Gorman,et al.  Benzoyl Peroxide Solubility and Stability in Hydric Solvents , 1992, Pharmaceutical Research.

[65]  W. Lambert,et al.  The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. , 1994, Archives of dermatology.

[66]  Shein-Chung Chow,et al.  Statistical Inference in Stability Analysis , 1994 .

[67]  C. Graffner.  Regulatory aspects of drug dissolution from a European perspective. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[68]  László Domokos.  Data About Data , 1988 .

[69]  R. Wrench.  Epidermal thinning: Evaluation of commercial corticosteroids , 2004, Archives of Dermatological Research.

[70]  T. Lindahl,et al.  DNA excision repair pathways. , 1997, Current opinion in genetics & development.

[71]  R. Anderson,et al.  The optics of human skin. , 1981, The Journal of investigative dermatology.